Erythromycin

Erythromycin has been studied in 5 papers since 2016: 2 observational studies in people, 1 in animals, 1 in cells, 1 review; 1 in the past year. The newest paper, Feb 11, 2026: “Association between urinary antibiotic exposure and blood pressure parameters in reproductive-age men: a biomonitoring-based cross-sectional study in China”.

Intervention

5 papers study it4 more mention it2 findingsUpdated

PubChemChEBIMeSH

See all 9 papers on erythromycin

At a glance

The findings reach worms or flies, none yet in people. 2 independent labs in 2 countries; 11 trials, none about aging, 7 with no results posted.

None of its findings points the other way.

Cells and worms or flies: a single group. Mice and humans: nothing yet.
  • 2 independent labs in 2 countries
  • 11 trials, none about aging, 7 with no results posted
  • Funders: Georgia Institute of Technology and 4 more
  • Humans2
  • Model organisms1
  • Cells1

What did studies of erythromycin find?

2

Studies of erythromycin measured 2 outcomes: cellular senescence and lifespan.

Cellular senescence

no changein human cells1

1 study
  1. Erythromycin showed no clear effect on cellular senescence in human cells after BrdU-induced senescence.

    “Erythromycin - the very closely-related parent compound - did not show any senolytic activity”

    Cellsafter BrdU-induced senescence

    Azithromycin and Roxithromycin define a new family of "senolytic" drugs that target senescent human fibroblasts

    Aging

More on Cellular senescence

Lifespan

upin Rotifera1

1 study
  1. Erythromycin extends lifespan in Rotifera.

    “Exposures to 1 μM erythromycin, 5 μM carglumic acid, 3 μM capecitabine, and 1 μM ivermectin, extended rotifer lifespan without significant effect on reproduction.”

    Model organisms1 μM

    Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers

    Biogerontology

Who is developing erythromycin?

1 company: AstraZeneca.

Companies

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months